• May 5, 2016

    TAKE ACTION! Tell HHS to Expand Access to Specialty Addiction Treatment!

    HHS's proposed rule on Medication Assisted Treatment for Opioid Use Disorders would raise the buprenorphine patient limit for qualified physicians from 100 to 200 patients, but ABAM-certified physicians do not qualify! Your voice is needed to tell HHS that ABAM-certified physicians should be eligible for the higher patient limit.
  • May 5, 2016

    ASAM Pleased FDA Announces Rule Extending Oversight of All Unregulated Tobacco Products

    On Thursday, May 5, the Food and Drug Administration issued a long-awaited rule to establish oversight of electronic cigarettes (e-cigarettes), cigars, hookah and other previously unregulated tobacco products.
  • May 3, 2016

    ASAM Collaboration with Brandeis and Cigna Tests Addiction Treatment Performance Measures

    ASAM is working with Brandeis University to test and validate three performance measures related to addiction treatment using commercial administrative data from the health insurer Cigna. This follows a recent project testing performance measures using data from the Veterans Health Administration.
  • April 25, 2016

    ASAM and NNESAM Call for Maine Legislature to Overturn Governor LePage’s Veto and Increase Access to Naloxone

    The American Society of Addiction Medicine (ASAM) and the Norther New England Society of Addiction Medicine (NNESAM) are calling for the Maine legislature to overturn Governor LePage’s veto of LD1547.
  • April 22, 2016

    Editorial Comment

    The opioid epidemic is finally reaching the average American's consciousness. This year, opioid overdoses have become an election year policy discussion for the presidential candidates. Additionally, 60 Minutes has run several primetime specials introducing the destruction caused by heroin and prescription opioid to every American household.
  • April 11, 2016

    Editorial Comment

    As specialists in addiction medicine we often face the task of educating those we treat, often by attempting to reduce a body of research to the most salient and actionable points and then presenting them in clear and understandable language. Our hope is usually a desire for them to leave with information that can improve their understanding, motivate to action, or both. In these one could argue we take on some of the job of the journalist.
  • April 5, 2016

    Letter of Thanks: Recognition of Addiction Medicine

    From the start, this endeavor was about the patients, and their affected family members. It was about building a workforce of trained and certified expert clinicians who would Treat Addiction and Save Lives™. We are today at a point in time, in a process begun by Dr. Ruth Fox and her colleagues in her apartment in New York City over 60 years ago, on the way to a future that we see clearly.
  • March 29, 2016

    ASAM Applauds Important Step by Obama Administration and Calls for Increased Congressional Pressure to Expand Treatment Access

    ASAM Applauds Important Step by Obama Administration and Calls for Increased Congressional Pressure to Expand Treatment Access
  • March 22, 2016

    Summary of Inter-Professional Collaboration

    A strong collaboration across different specialties is essential to produce a comprehensive treatment plan. This article highlights key points to consider in supporting inter-professional collaboration.
  • March 21, 2016

    Editorial Comment

    "Be careful what you ask for." In our discipline's quest for comprehensive guidelines for the management of opioid medications, these have been provided by the CDC in the past week, and are linked below. Depending on formatting, the reader will see over 50 pages, the greater part of which is, appropriately, discussion of the evidence for and against opioid use practices; “appropriately,” given the contentions associated with this topic. Naturally, that sort of reading assignment encourages condensation.
  • March 16, 2016

    U.S. Senate Shows Leadership in Bipartisan Response to Opioid Epidemic

    The United States Senate almost unanimously passed the first legislation to address addiction and drug use in over a decade.
  • March 15, 2016

    ASAM Applauds HHS and CDC for Guidelines on Prescribing Opioids for Chronic Pain

    The Centers for Disease Control and Prevention (CDC) for issued new recommendations for prescribing opioid medications for chronic pain, excluding cancer, palliative and end-of-life care.
  • March 14, 2016

    ASAM Celebrates as Addiction Medicine is Recognized as New Medical Subspecialty

    Addiction Medicine moves into the 21st century.
  • March 11, 2016

    One Insurer’s Efforts to Assist in Massachusetts’ Opioid Overdose Crisis

    The Payer Relations Committee seeks to build a working relationship with health insurers and other payers across the country. One way that we will be engaging with payers is by featuring in the ASAM Magazine health insurers that are working to increase access to treatment for plan members with addiction. This will be the first in a series of articles that will highlight payers working to improve access to substance use disorder treatment.
  • March 3, 2016

    ASAM Endorses ACOG Report on Team-Based Care

    ASAM endorsed the recent report from the American Congress of Obstetricians and Gynecologists entitled Collaboration in Practice: Implementing Team-Based Care. In the words of the report, it "will be most useful for those who are charged with developing new practice models based on the changing demographics of health care practices and financial reimbursement structures."